Sunshine Lake Pharma Co., Ltd. RX
FDA Approved Drugs
Sunshine Lake Pharma Co., Ltd. RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 61
- Latest Approval Date Oct 28, 2025
- Data Source FDA
- First Approval Date Jul 09, 2018
Company Overview
Company
Sunshine Lake Pharma Co., Ltd. RX
Country
China
Website
Social Profiles
Company Snapshot
Sunshine Lake Pharma Co., Ltd. RX
HEC Pharm Group , Dong Yang Guang Park, Shangsha, Chang’an, Dongguan, Guangdong, 523871, China
China
www.hecpharm.com/ sales@hecpharm.com View on MapFDA Approved Drug Records ( 61 records )
Drug Name
ARIPIPRAZOLE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2023-10-02
Active Ingredient
ARIPIPRAZOLE
Application Number
213037
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2023-10-02
Regulatory Status
RX
Drug Name
ARIPIPRAZOLE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2023-10-02
Active Ingredient
ARIPIPRAZOLE
Application Number
213037
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2023-10-02
Regulatory Status
RX
Drug Name
ARIPIPRAZOLE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2023-10-02
Active Ingredient
ARIPIPRAZOLE
Application Number
213037
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2023-10-02
Regulatory Status
RX
Drug Name
AZITHROMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 600MG BASE
Approval Date
2018-12-06
Active Ingredient
AZITHROMYCIN
Application Number
209043
Product Number
1
Dosage Form
-
Strength
EQ 600MG BASE
Approval Date
2018-12-06
Regulatory Status
RX
Drug Name
AZITHROMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2018-12-07
Active Ingredient
AZITHROMYCIN
Application Number
209044
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2018-12-07
Regulatory Status
RX
Drug Name
AZITHROMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2018-12-07
Active Ingredient
AZITHROMYCIN
Application Number
209045
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2018-12-07
Regulatory Status
RX
Drug Name
BRIVARACETAM
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2022-06-09
Active Ingredient
BRIVARACETAM
Application Number
214748
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2022-06-09
Regulatory Status
RX
Drug Name
BRIVARACETAM
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2022-06-09
Active Ingredient
BRIVARACETAM
Application Number
214748
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2022-06-09
Regulatory Status
RX
Drug Name
BRIVARACETAM
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2022-06-09
Active Ingredient
BRIVARACETAM
Application Number
214748
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2022-06-09
Regulatory Status
RX
Drug Name
BRIVARACETAM
Product Number
4
Dosage Form
-
Strength
75MG
Approval Date
2022-06-09
Active Ingredient
BRIVARACETAM
Application Number
214748
Product Number
4
Dosage Form
-
Strength
75MG
Approval Date
2022-06-09
Regulatory Status
RX
Drug Name
BRIVARACETAM
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2022-06-09
Active Ingredient
BRIVARACETAM
Application Number
214748
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2022-06-09
Regulatory Status
RX
Drug Name
CLARITHROMYCIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2018-07-09
Active Ingredient
CLARITHROMYCIN
Application Number
208987
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2018-07-09
Regulatory Status
RX
Drug Name
DULOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2021-02-11
Active Ingredient
DULOXETINE HYDROCHLORIDE
Application Number
212328
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
DULOXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2021-02-11
Active Ingredient
DULOXETINE HYDROCHLORIDE
Application Number
212328
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
DULOXETINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2021-02-11
Active Ingredient
DULOXETINE HYDROCHLORIDE
Application Number
212328
Product Number
3
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
ENTACAPONE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2018-10-03
Active Ingredient
ENTACAPONE
Application Number
206669
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2018-10-03
Regulatory Status
RX
Drug Name
FEBUXOSTAT
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2020-06-02
Active Ingredient
FEBUXOSTAT
Application Number
213069
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2020-06-02
Regulatory Status
RX
Drug Name
FEBUXOSTAT
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2020-06-02
Active Ingredient
FEBUXOSTAT
Application Number
213069
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2020-06-02
Regulatory Status
RX
Drug Name
LINAGLIPTIN
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2021-08-31
Active Ingredient
LINAGLIPTIN
Application Number
208335
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2021-08-31
Regulatory Status
RX
Drug Name
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2021-08-30
Active Ingredient
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Application Number
208336
Product Number
1
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2021-08-30
Regulatory Status
RX
Drug Name
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2.5MG;850MG
Approval Date
2021-08-30
Active Ingredient
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Application Number
208336
Product Number
2
Dosage Form
-
Strength
2.5MG;850MG
Approval Date
2021-08-30
Regulatory Status
RX
Drug Name
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
2.5MG;1GM
Approval Date
2021-08-30
Active Ingredient
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Application Number
208336
Product Number
3
Dosage Form
-
Strength
2.5MG;1GM
Approval Date
2021-08-30
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 50MG TARTRATE
Approval Date
2022-09-26
Active Ingredient
METOPROLOL SUCCINATE
Application Number
214004
Product Number
1
Dosage Form
-
Strength
EQ 50MG TARTRATE
Approval Date
2022-09-26
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 100MG TARTRATE
Approval Date
2022-09-26
Active Ingredient
METOPROLOL SUCCINATE
Application Number
214004
Product Number
2
Dosage Form
-
Strength
EQ 100MG TARTRATE
Approval Date
2022-09-26
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 200MG TARTRATE
Approval Date
2022-09-26
Active Ingredient
METOPROLOL SUCCINATE
Application Number
214004
Product Number
3
Dosage Form
-
Strength
EQ 200MG TARTRATE
Approval Date
2022-09-26
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
4
Dosage Form
-
Strength
EQ 25MG TARTRATE
Approval Date
2024-05-23
Active Ingredient
METOPROLOL SUCCINATE
Application Number
214004
Product Number
4
Dosage Form
-
Strength
EQ 25MG TARTRATE
Approval Date
2024-05-23
Regulatory Status
RX
Drug Name
MOXIFLOXACIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2018-09-28
Active Ingredient
MOXIFLOXACIN HYDROCHLORIDE
Application Number
206295
Product Number
1
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2018-09-28
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLANZAPINE
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2018-11-19
Active Ingredient
OLANZAPINE
Application Number
206238
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2018-11-19
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-02-22
Active Ingredient
OLMESARTAN MEDOXOMIL
Application Number
211049
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-02-22
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2019-02-22
Active Ingredient
OLMESARTAN MEDOXOMIL
Application Number
211049
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2019-02-22
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2019-02-22
Active Ingredient
OLMESARTAN MEDOXOMIL
Application Number
211049
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2019-02-22
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2020-03-04
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
212739
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2020-03-04
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
2
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2020-03-04
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
212739
Product Number
2
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2020-03-04
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
3
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-03-04
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
212739
Product Number
3
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-03-04
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2022-01-05
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
213594
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2022-01-05
Regulatory Status
RX
Drug Name
RANOLAZINE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2020-03-23
Active Ingredient
RANOLAZINE
Application Number
211865
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2020-03-23
Regulatory Status
RX
Drug Name
RANOLAZINE
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2020-03-23
Active Ingredient
RANOLAZINE
Application Number
211865
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2020-03-23
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
213348
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
213348
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
213348
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2020-04-01
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
210667
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2020-04-01
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-04-01
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
210667
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-04-01
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2020-04-01
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
210667
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2020-04-01
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2020-04-01
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
210667
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2020-04-01
Regulatory Status
RX
Drug Name
SILDENAFIL CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-06-11
Active Ingredient
SILDENAFIL CITRATE
Application Number
213032
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-06-11
Regulatory Status
RX
Drug Name
SILDENAFIL CITRATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2020-06-11
Active Ingredient
SILDENAFIL CITRATE
Application Number
213032
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2020-06-11
Regulatory Status
RX
Drug Name
SILDENAFIL CITRATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-06-11
Active Ingredient
SILDENAFIL CITRATE
Application Number
213032
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-06-11
Regulatory Status
RX
Drug Name
SOLIFENACIN SUCCINATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-04-13
Active Ingredient
SOLIFENACIN SUCCINATE
Application Number
213346
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-04-13
Regulatory Status
RX
Drug Name
SOLIFENACIN SUCCINATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-04-13
Active Ingredient
SOLIFENACIN SUCCINATE
Application Number
213346
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-04-13
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2019-03-26
Active Ingredient
TADALAFIL
Application Number
211335
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2019-03-26
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2019-03-26
Active Ingredient
TADALAFIL
Application Number
211335
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2019-03-26
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2019-03-26
Active Ingredient
TADALAFIL
Application Number
211335
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2019-03-26
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2019-03-26
Active Ingredient
TADALAFIL
Application Number
211335
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2019-03-26
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2020-11-23
Active Ingredient
TADALAFIL
Application Number
213496
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2020-11-23
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
1
Dosage Form
-
Strength
90MG
Approval Date
2020-04-06
Active Ingredient
TICAGRELOR
Application Number
208508
Product Number
1
Dosage Form
-
Strength
90MG
Approval Date
2020-04-06
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
2
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Active Ingredient
TICAGRELOR
Application Number
208508
Product Number
2
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Regulatory Status
RX
Drug Status Breakdown
61 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ARIPIPRAZOLE
Application Number
213037
Product Number
1
Active Ingredient
ARIPIPRAZOLE
Dosage Form
-
Strength
2MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.